{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:39:06Z","timestamp":1791653946451,"version":"4.3.4"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2019-12369523"],"award-info":[{"award-number":["GR-2019-12369523"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2019-12369523"],"award-info":[{"award-number":["GR-2019-12369523"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001230","name":"Macquarie University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00406-022-01519-0","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T19:02:57Z","timestamp":1670007777000},"page":"1317-1328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Importance of the dysregulation of the kynurenine pathway on cognition in schizophrenia: a systematic review of clinical studies"],"prefix":"10.1007","volume":"273","author":[{"given":"Jacopo","family":"Sapienza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Spangaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles J.","family":"Guillemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5686-7194","authenticated-orcid":false,"given":"Stefano","family":"Comai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bosia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,2]]},"reference":[{"key":"1519_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2009.03.005","volume":"110","author":"R Tandon","year":"2009","unstructured":"Tandon R, Nasrallah HA, Keshavan MS (2009) Schizophrenia, \u201cjust the facts\u201d 4. Clinical features and conceptualization. Schizophr Res 110:1\u201323. https:\/\/doi.org\/10.1016\/j.schres.2009.03.005","journal-title":"Schizophr Res"},{"key":"1519_CR2","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/J.PSYCHRES.2017.02.019","volume":"251","author":"M Bechi","year":"2017","unstructured":"Bechi M, Bosia M, Spangaro M et al (2017) Exploring functioning in schizophrenia: predictors of functional capacity and real-world behaviour. Psychiatry Res 251:118\u2013124. https:\/\/doi.org\/10.1016\/J.PSYCHRES.2017.02.019","journal-title":"Psychiatry Res"},{"key":"1519_CR3","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s00406-022-01416-6","volume":"272","author":"Y Gebreegziabhere","year":"2022","unstructured":"Gebreegziabhere Y, Habatmu K, Mihretu A et al (2022) Cognitive impairment in people with schizophrenia: an umbrella review. Eur Arch Psychiatry Clin Neurosci 272:1139\u20131155. https:\/\/doi.org\/10.1007\/s00406-022-01416-6","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1519_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/SCHBUL\/SBQ002","volume":"36","author":"I Wonodi","year":"2010","unstructured":"Wonodi I, Schwarcz R (2010) Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in schizophrenia. Schizophr Bull 36:211\u2013218. https:\/\/doi.org\/10.1093\/SCHBUL\/SBQ002","journal-title":"Schizophr Bull"},{"key":"1519_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1017\/S109285291900124X","volume":"24","author":"A Krogmann","year":"2019","unstructured":"Krogmann A, Peters L, Von Hardenberg L et al (2019) Keeping up with the therapeutic advances in schizophrenia: a review of novel and emerging pharmacological entities. CNS Spectr 24:41\u201368. https:\/\/doi.org\/10.1017\/S109285291900124X","journal-title":"CNS Spectr"},{"key":"1519_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000512082","volume":"80","author":"M Bosia","year":"2021","unstructured":"Bosia M, Spangaro M, Sapienza J et al (2021) Cognition in schizophrenia: modeling the interplay between interleukin-1\u03b2 C-511T polymorphism, metabolic syndrome, and sex. Neuropsychobiology 80:321\u2013332. https:\/\/doi.org\/10.1159\/000512082","journal-title":"Neuropsychobiology"},{"key":"1519_CR7","doi-asserted-by":"publisher","first-page":"11821","DOI":"10.1038\/S41598-017-12027-W","volume":"7","author":"B Zhang","year":"2017","unstructured":"Zhang B, Han M, Tan S et al (2017) Gender differences measured by the MATRICS consensus cognitive battery in chronic schizophrenia patients. Sci Rep 7:11821. https:\/\/doi.org\/10.1038\/S41598-017-12027-W","journal-title":"Sci Rep"},{"key":"1519_CR8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.2174\/138161212799316217","volume":"18","author":"D. Howes O, Fusar-Poli P, Bloomfiel","year":"2012","unstructured":"D. Howes O, Fusar-Poli P, Bloomfield M, et al (2012) From the prodrome to chronic schizophrenia: the neurobiology underlying psychotic symptoms and cognitive impairments. Curr Pharm Des 18:459\u2013465. https:\/\/doi.org\/10.2174\/138161212799316217","journal-title":"Curr Pharm Des"},{"key":"1519_CR9","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/schbul\/sbp006","volume":"35","author":"OD Howes","year":"2009","unstructured":"Howes OD, Kapur S (2009) The dopamine hypothesis of schizophrenia: version III\u2014the final common pathway. Schizophr Bull 35:549\u2013562. https:\/\/doi.org\/10.1093\/schbul\/sbp006","journal-title":"Schizophr Bull"},{"key":"1519_CR10","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S0006-3223(99)00116-X","volume":"46","author":"TS Braver","year":"1999","unstructured":"Braver TS, Barch DM, Cohen JD (1999) Cognition and control in schizophrenia: a computational model of dopamine and prefrontal function. Biol Psychiatry 46:312\u2013328. https:\/\/doi.org\/10.1016\/S0006-3223(99)00116-X","journal-title":"Biol Psychiatry"},{"key":"1519_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1080\/21642850.2014.905206","volume":"2","author":"M Bosia","year":"2014","unstructured":"Bosia M, Bechi M, Pirovano A et al (2014) COMT and 5-HT1A-receptor genotypes potentially affect executive functions improvement after cognitive remediation in schizophrenia. Heal Psychol Behav Med 2:509\u2013516. https:\/\/doi.org\/10.1080\/21642850.2014.905206","journal-title":"Heal Psychol Behav Med"},{"key":"1519_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/S10072-014-1936-9","volume":"36","author":"M Bosia","year":"2015","unstructured":"Bosia M, Pigoni A, Pirovano A et al (2015) COMT and STH polymorphisms interaction on cognition in schizophrenia. Neurol Sci 36:215\u2013220. https:\/\/doi.org\/10.1007\/S10072-014-1936-9","journal-title":"Neurol Sci"},{"key":"1519_CR13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.neulet.2007.02.076","volume":"417","author":"M Bosia","year":"2007","unstructured":"Bosia M, Bechi M, Marino E et al (2007) Influence of catechol-O-methyltransferase Val158Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia. Neurosci Lett 417:271\u2013274. https:\/\/doi.org\/10.1016\/j.neulet.2007.02.076","journal-title":"Neurosci Lett"},{"key":"1519_CR14","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/SREP00677","volume":"2","author":"Q He","year":"2012","unstructured":"He Q, Xue G, Chen C et al (2012) COMT Val158Met polymorphism interacts with stressful life events and parental warmth to influence decision making. Sci Rep 2:677. https:\/\/doi.org\/10.1038\/SREP00677","journal-title":"Sci Rep"},{"key":"1519_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/HUP.2758","volume":"36","author":"MM Koola","year":"2021","unstructured":"Koola MM (2021) Alpha7 nicotinic-N-methyl-d-aspartate hypothesis in the treatment of schizophrenia and beyond. Hum Psychopharmacol 36:1\u201316. https:\/\/doi.org\/10.1002\/HUP.2758","journal-title":"Hum Psychopharmacol"},{"key":"1519_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/J.NEULET.2012.06.030","volume":"522","author":"M Spangaro","year":"2012","unstructured":"Spangaro M, Bosia M, Zanoletti A et al (2012) Cognitive dysfunction and glutamate reuptake: effect of EAAT2 polymorphism in schizophrenia. Neurosci Lett 522:151\u2013155. https:\/\/doi.org\/10.1016\/J.NEULET.2012.06.030","journal-title":"Neurosci Lett"},{"key":"1519_CR17","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2217\/PGS.14.42","volume":"15","author":"M Spangaro","year":"2014","unstructured":"Spangaro M, Bosia M, Zanoletti A et al (2014) Exploring effects of EAAT polymorphisms on cognitive functions in schizophrenia. Pharmacogenomics 15:925\u2013932. https:\/\/doi.org\/10.2217\/PGS.14.42","journal-title":"Pharmacogenomics"},{"key":"1519_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","volume":"2","author":"GM Khandaker","year":"2015","unstructured":"Khandaker GM, Cousins L, Deakin J et al (2015) Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. Lancet Psychiatry 2:258\u2013270. https:\/\/doi.org\/10.1016\/S2215-0366(14)00122-9","journal-title":"Lancet Psychiatry"},{"key":"1519_CR19","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00406-019-01073-2","volume":"270","author":"S Kogan","year":"2019","unstructured":"Kogan S, Ospina LH, Mittal VA, Kimhy D (2019) The impact of inflammation on neurocognition and risk for psychosis: a critical review. Eur Arch Psychiatry Clin Neurosci 270:793\u2013802. https:\/\/doi.org\/10.1007\/s00406-019-01073-2","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1519_CR20","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s00406-021-01363-8","volume":"272","author":"S Yamada","year":"2022","unstructured":"Yamada S, Takahashi S, Malchow B et al (2022) Cognitive and functional deficits are associated with white matter abnormalities in two independent cohorts of patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci 272:957\u2013969. https:\/\/doi.org\/10.1007\/s00406-021-01363-8","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1519_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.pnpbp.2012.10.022","volume":"48","author":"KS Na","year":"2014","unstructured":"Na KS, Jung HY, Kim YK (2014) The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry 48:277\u2013286. https:\/\/doi.org\/10.1016\/j.pnpbp.2012.10.022","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"1519_CR22","doi-asserted-by":"publisher","first-page":"e1171","DOI":"10.1038\/TP.2017.138","volume":"7","author":"DA Maas","year":"2017","unstructured":"Maas DA, Vall\u00e8s A, Martens GJM (2017) Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia. Transl Psychiatry 7:e1171. https:\/\/doi.org\/10.1038\/TP.2017.138","journal-title":"Transl Psychiatry"},{"key":"1519_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41398-021-01475-8","volume":"11","author":"LP Smirnova","year":"2021","unstructured":"Smirnova LP, Yarnykh VL, Parshukova DA et al (2021) Global hypomyelination of the brain white and gray matter in schizophrenia: quantitative imaging using macromolecular proton fraction. Transl Psychiatry 11:365. https:\/\/doi.org\/10.1038\/s41398-021-01475-8","journal-title":"Transl Psychiatry"},{"key":"1519_CR24","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.euroneuro.2018.12.008","volume":"29","author":"MN Noto","year":"2019","unstructured":"Noto MN, Maes M, Nunes SOV et al (2019) Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis. Eur Neuropsychopharmacol 29:416\u2013431. https:\/\/doi.org\/10.1016\/j.euroneuro.2018.12.008","journal-title":"Eur Neuropsychopharmacol"},{"key":"1519_CR25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/BS.ACC.2019.08.005","volume":"95","author":"S Comai","year":"2020","unstructured":"Comai S, Bertazzo A, Brughera M, Crotti S (2020) Tryptophan in health and disease. Adv Clin Chem 95:165\u2013218. https:\/\/doi.org\/10.1016\/BS.ACC.2019.08.005","journal-title":"Adv Clin Chem"},{"key":"1519_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/J.EURONEURO.2021.11.003","volume":"55","author":"S Comai","year":"2022","unstructured":"Comai S, Melloni E, Lorenzi C et al (2022) Selective association of cytokine levels and kynurenine\/tryptophan ratio with alterations in white matter microstructure in bipolar but not in unipolar depression. Eur Neuropsychopharmacol 55:96\u2013109. https:\/\/doi.org\/10.1016\/J.EURONEURO.2021.11.003","journal-title":"Eur Neuropsychopharmacol"},{"key":"1519_CR27","doi-asserted-by":"publisher","first-page":"108055","DOI":"10.1016\/J.PHARMTHERA.2021.108055","volume":"236","author":"AS Pires","year":"2021","unstructured":"Pires AS, Sundaram G, Heng B et al (2021) Recent advances in clinical trials targeting the kynurenine pathway. Pharmacol Ther 236:108055. https:\/\/doi.org\/10.1016\/J.PHARMTHERA.2021.108055","journal-title":"Pharmacol Ther"},{"key":"1519_CR28","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1038\/S41380-019-0401-9","volume":"25","author":"J Kindler","year":"2020","unstructured":"Kindler J, Lim CK, Weickert CS et al (2020) Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia. Mol Psychiatry 25:2860\u20132872. https:\/\/doi.org\/10.1038\/S41380-019-0401-9","journal-title":"Mol Psychiatry"},{"key":"1519_CR29","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/S12640-016-9641-5","volume":"30","author":"J de Bie","year":"2016","unstructured":"de Bie J, Lim CK, Guillemin GJ (2016) Kynurenines, gender and neuroinflammation; showcase schizophrenia. Neurotox Res 30:285\u2013294. https:\/\/doi.org\/10.1007\/S12640-016-9641-5","journal-title":"Neurotox Res"},{"key":"1519_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/J.NEUROPHARM.2016.08.003","volume":"112","author":"R Schwarcz","year":"2017","unstructured":"Schwarcz R, Stone TW (2017) The kynurenine pathway and the brain: challenges, controversies and promises. Neuropharmacology 112:237\u2013247. https:\/\/doi.org\/10.1016\/J.NEUROPHARM.2016.08.003","journal-title":"Neuropharmacology"},{"key":"1519_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4137\/IJTR.S3804","volume":"3","author":"S Comai","year":"2010","unstructured":"Comai S, Bertazzo A, Carretti N et al (2010) Serum levels of tryptophan, 5-hydroxytryptophan and serotonin in patients affected with different forms of amenorrhea. Int J Tryptophan Res 3:69\u201375. https:\/\/doi.org\/10.4137\/IJTR.S3804","journal-title":"Int J Tryptophan Res"},{"key":"1519_CR32","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1093\/HUMREP\/DEH795","volume":"20","author":"N Carretti","year":"2005","unstructured":"Carretti N, Florio P, Bertolin A et al (2005) Serum fluctuations of total and free tryptophan levels during the menstrual cycle are related to gonadotrophins and reflect brain serotonin utilization. Hum Reprod 20:1548\u20131553. https:\/\/doi.org\/10.1093\/HUMREP\/DEH795","journal-title":"Hum Reprod"},{"key":"1519_CR33","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/13697130701378198","volume":"10","author":"N Carretti","year":"2007","unstructured":"Carretti N, Florio P, Reis FM et al (2007) Menopause alters the metabolism of serum serotonin precursors and their correlation with gonadotropins and estradiol. Climacteric 10:393\u2013399. https:\/\/doi.org\/10.1080\/13697130701378198","journal-title":"Climacteric"},{"key":"1519_CR34","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/JNC.13496","volume":"136","author":"J De Bie","year":"2016","unstructured":"De Bie J, Guest J, Guillemin GJ, Grant R (2016) Central kynurenine pathway shift with age in women. J Neurochem 136:995\u20131003. https:\/\/doi.org\/10.1111\/JNC.13496","journal-title":"J Neurochem"},{"key":"1519_CR35","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/NRN3257","volume":"13","author":"R Schwarcz","year":"2012","unstructured":"Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ (2012) Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 13:465\u2013477. https:\/\/doi.org\/10.1038\/NRN3257","journal-title":"Nat Rev Neurosci"},{"key":"1519_CR36","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1007\/S12035-019-01737-Z","volume":"57","author":"C Roomruangwong","year":"2020","unstructured":"Roomruangwong C, Noto C, Kanchanatawan B et al (2020) The role of aberrations in the immune-inflammatory response system (IRS) and the compensatory immune-regulatory reflex system (CIRS) in different phenotypes of schizophrenia: the IRS-CIRS theory of schizophrenia. Mol Neurobiol 57:778\u2013797. https:\/\/doi.org\/10.1007\/S12035-019-01737-Z","journal-title":"Mol Neurobiol"},{"key":"1519_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/J.CCCN.2005.04.013","volume":"360","author":"S Comai","year":"2005","unstructured":"Comai S, Costa CVL, Ragazzi E et al (2005) The effect of age on the enzyme activities of tryptophan metabolism along the kynurenine pathway in rats. Clin Chim Acta 360:67\u201380. https:\/\/doi.org\/10.1016\/J.CCCN.2005.04.013","journal-title":"Clin Chim Acta"},{"key":"1519_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuint.2019.02.001","volume":"125","author":"H Fujigaki","year":"2019","unstructured":"Fujigaki H, Mouri A, Yamamoto Y et al (2019) Linking phencyclidine intoxication to the tryptophan\u2013kynurenine pathway: therapeutic implications for schizophrenia. Neurochem Int 125:1\u20136. https:\/\/doi.org\/10.1016\/j.neuint.2019.02.001","journal-title":"Neurochem Int"},{"key":"1519_CR39","doi-asserted-by":"publisher","first-page":"7463","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001","volume":"21","author":"C Hilmas","year":"2001","unstructured":"Hilmas C, Pereira EFR, Alkondon M et al (2001) The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci 21:7463\u20137473. https:\/\/doi.org\/10.1523\/JNEUROSCI.21-19-07463.2001","journal-title":"J Neurosci"},{"key":"1519_CR40","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.2174\/1381612822666160127114010","volume":"22","author":"A Gibbons","year":"2016","unstructured":"Gibbons A, Dean B (2016) The cholinergic system: an emerging drug target for schizophrenia. Curr Pharm Des 22:2124\u20132133. https:\/\/doi.org\/10.2174\/1381612822666160127114010","journal-title":"Curr Pharm Des"},{"key":"1519_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000515066","volume":"7","author":"MY Bai","year":"2021","unstructured":"Bai MY, Lovejoy DB, Guillemin GJ et al (2021) Galantamine\u2013memantine combination and kynurenine pathway enzyme inhibitors in the treatment of neuropsychiatric disorders. Complex psychiatry 7:19\u201333. https:\/\/doi.org\/10.1159\/000515066","journal-title":"Complex psychiatry"},{"key":"1519_CR42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.pnpbp.2012.06.014","volume":"42","author":"G Anderson","year":"2013","unstructured":"Anderson G, Maes M (2013) Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression. Prog Neuro-Psychopharmacol Biol Psychiatry 42:5\u201319. https:\/\/doi.org\/10.1016\/j.pnpbp.2012.06.014","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"1519_CR43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/7854_2018_88","volume":"44","author":"R Upthegrove","year":"2020","unstructured":"Upthegrove R, Khandaker GM (2020) Cytokines, oxidative stress and cellular markers of inflammation in schizophrenia. Curr Top Behav Neurosci 44:49\u201366. https:\/\/doi.org\/10.1007\/7854_2018_88","journal-title":"Curr Top Behav Neurosci"},{"key":"1519_CR44","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.biopsych.2013.03.018","volume":"74","author":"J Flatow","year":"2013","unstructured":"Flatow J, Buckley P, Miller BJ (2013) Meta-analysis of oxidative stress in schizophrenia. Biol Psychiatry 74:400\u2013409. https:\/\/doi.org\/10.1016\/j.biopsych.2013.03.018","journal-title":"Biol Psychiatry"},{"key":"1519_CR45","doi-asserted-by":"publisher","first-page":"e1024","DOI":"10.1038\/tp.2016.278","volume":"7","author":"OD Howes","year":"2017","unstructured":"Howes OD, McCutcheon R (2017) Inflammation and the neural diathesis\u2013stress hypothesis of schizophrenia: a reconceptualization. Transl Psychiatry 7:e1024\u2013e1111. https:\/\/doi.org\/10.1038\/tp.2016.278","journal-title":"Transl Psychiatry"},{"key":"1519_CR46","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","volume":"70","author":"BJ Miller","year":"2011","unstructured":"Miller BJ, Buckley P, Seabolt W et al (2011) Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 70:663\u2013671. https:\/\/doi.org\/10.1016\/j.biopsych.2011.04.013","journal-title":"Biol Psychiatry"},{"key":"1519_CR47","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3389\/FPSYT.2019.00892","volume":"10","author":"S Momtazmanesh","year":"2019","unstructured":"Momtazmanesh S, Zare-Shahabadi A, Rezaei N (2019) Cytokine alterations in schizophrenia: an updated review. Front Psychiatry 10:892. https:\/\/doi.org\/10.3389\/FPSYT.2019.00892","journal-title":"Front Psychiatry"},{"key":"1519_CR48","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1038\/S41386-018-0038-4","volume":"43","author":"J Chiappelli","year":"2018","unstructured":"Chiappelli J, Notarangelo FM, Pocivavsek A et al (2018) Influence of plasma cytokines on kynurenine and kynurenic acid in schizophrenia. Neuropsychopharmacology 43:1675\u20131680. https:\/\/doi.org\/10.1038\/S41386-018-0038-4","journal-title":"Neuropsychopharmacology"},{"key":"1519_CR49","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/S41380-019-0414-4","volume":"25","author":"J Savitz","year":"2020","unstructured":"Savitz J (2020) The kynurenine pathway: a finger in every pie. Mol Psychiatry 25:131\u2013147. https:\/\/doi.org\/10.1038\/S41380-019-0414-4","journal-title":"Mol Psychiatry"},{"key":"1519_CR50","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1007\/S00213-014-3452-2","volume":"231","author":"A Pocivavsek","year":"2014","unstructured":"Pocivavsek A, Thomas MAR, Elmer GI et al (2014) Continuous kynurenine administration during the prenatal period, but not during adolescence, causes learning and memory deficits in adult rats. Psychopharmacology 231:2799\u20132809. https:\/\/doi.org\/10.1007\/S00213-014-3452-2","journal-title":"Psychopharmacology"},{"key":"1519_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/J.NEUROPHARM.2014.10.017","volume":"90","author":"ML Pershing","year":"2015","unstructured":"Pershing ML, Bortz DM, Pocivavsek A et al (2015) Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: implications for schizophrenia. Neuropharmacology 90:33\u201341. https:\/\/doi.org\/10.1016\/J.NEUROPHARM.2014.10.017","journal-title":"Neuropharmacology"},{"key":"1519_CR52","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/J.BIOPSYCH.2016.12.011","volume":"82","author":"S Erhardt","year":"2017","unstructured":"Erhardt S, Pocivavsek A, Repici M et al (2017) Adaptive and behavioral changes in kynurenine 3-monooxygenase knockout mice: relevance to psychotic disorders. Biol Psychiatry 82:756\u2013765. https:\/\/doi.org\/10.1016\/J.BIOPSYCH.2016.12.011","journal-title":"Biol Psychiatry"},{"key":"1519_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/S41380-022-01552-4","author":"AF Almulla","year":"2022","unstructured":"Almulla AF, Vasupanrajit A, Tunvirachaisakul C et al (2022) The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments. Mol Psychiatry. https:\/\/doi.org\/10.1038\/S41380-022-01552-4","journal-title":"Mol Psychiatry"},{"key":"1519_CR54","doi-asserted-by":"publisher","first-page":"5184","DOI":"10.1007\/S12035-017-0751-8","volume":"55","author":"B Kanchanatawan","year":"2018","unstructured":"Kanchanatawan B, Hemrungrojn S, Thika S et al (2018) Changes in tryptophan catabolite (TRYCAT) pathway patterning are associated with mild impairments in declarative memory in schizophrenia and deficits in semantic and episodic memory coupled with increased false-memory creation in deficit schizophrenia. Mol Neurobiol 55:5184\u20135201. https:\/\/doi.org\/10.1007\/S12035-017-0751-8","journal-title":"Mol Neurobiol"},{"key":"1519_CR55","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0165-1781(89)90153-4","volume":"30","author":"B Kirkpatrick","year":"1989","unstructured":"Kirkpatrick B, Buchanan RW, McKenny PD et al (1989) The schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res 30:119\u2013123. https:\/\/doi.org\/10.1016\/0165-1781(89)90153-4","journal-title":"Psychiatry Res"},{"key":"1519_CR56","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/J.2051-5545.2008.TB00181.X","volume":"7","author":"B Kirkpatrick","year":"2008","unstructured":"Kirkpatrick B, Galderisi S (2008) Deficit schizophrenia: an update. World Psychiatry 7:143\u2013147. https:\/\/doi.org\/10.1002\/J.2051-5545.2008.TB00181.X","journal-title":"World Psychiatry"},{"key":"1519_CR57","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/JNP.12161","volume":"13","author":"M Bechi","year":"2019","unstructured":"Bechi M, Spangaro M, Agostoni G et al (2019) Intellectual and cognitive profiles in patients affected by schizophrenia. J Neuropsychol 13:589\u2013602. https:\/\/doi.org\/10.1111\/JNP.12161","journal-title":"J Neuropsychol"},{"key":"1519_CR58","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2147\/NDT.S239763","volume":"16","author":"X Huang","year":"2020","unstructured":"Huang X, Ding W, Wu F et al (2020) Increased plasma kynurenic acid levels are associated with impaired attention\/vigilance and social cognition in patients with schizophrenia. Neuropsychiatr Dis Treat 16:263\u2013271. https:\/\/doi.org\/10.2147\/NDT.S239763","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1519_CR59","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/S41398-021-01311-Z","volume":"11","author":"J Huang","year":"2021","unstructured":"Huang J, Tong J, Zhang P et al (2021) Effects of neuroactive metabolites of the tryptophan pathway on working memory and cortical thickness in schizophrenia. Transl Psychiatry 11:198. https:\/\/doi.org\/10.1038\/S41398-021-01311-Z","journal-title":"Transl Psychiatry"},{"key":"1519_CR60","doi-asserted-by":"publisher","first-page":"9992","DOI":"10.1038\/S41598-021-89335-9","volume":"11","author":"F Cathomas","year":"2021","unstructured":"Cathomas F, Guetter K, Seifritz E et al (2021) Quinolinic acid is associated with cognitive deficits in schizophrenia but not major depressive disorder. Sci Rep 11:9992. https:\/\/doi.org\/10.1038\/S41598-021-89335-9","journal-title":"Sci Rep"},{"key":"1519_CR61","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/J.SCHRES.2021.01.014","volume":"229","author":"H Noyan","year":"2021","unstructured":"Noyan H, Erda\u011f E, T\u00fcz\u00fcn E et al (2021) Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1\u03b2 levels in patients with schizophrenia spectrum disorder and their siblings. Schizophr Res 229:27\u201337. https:\/\/doi.org\/10.1016\/J.SCHRES.2021.01.014","journal-title":"Schizophr Res"},{"key":"1519_CR62","doi-asserted-by":"publisher","first-page":"117864691986897","DOI":"10.1177\/1178646919868978","volume":"12","author":"AAB Badawy","year":"2019","unstructured":"Badawy AAB, Guillemin G (2019) The plasma [kynurenine]\/[tryptophan] ratio and indoleamine 2,3-dioxygenase: time for appraisal. Int J Tryptophan Res 12:1178646919868978. https:\/\/doi.org\/10.1177\/1178646919868978","journal-title":"Int J Tryptophan Res"},{"key":"1519_CR63","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1111\/J.1471-4159.1991.TB03460.X","volume":"56","author":"S Fukui","year":"1991","unstructured":"Fukui S, Schwarcz R, Rapoport SI et al (1991) Blood\u2013brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J Neurochem 56:2007\u20132017. https:\/\/doi.org\/10.1111\/J.1471-4159.1991.TB03460.X","journal-title":"J Neurochem"},{"key":"1519_CR64","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S2215-0366(17)30293-6","volume":"5","author":"TA Pollak","year":"2018","unstructured":"Pollak TA, Drndarski S, Stone JM et al (2018) The blood\u2013brain barrier in psychosis. Lancet Psychiatry 5:79\u201392. https:\/\/doi.org\/10.1016\/S2215-0366(17)30293-6","journal-title":"Lancet Psychiatry"},{"key":"1519_CR65","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.3390\/JCM11092517","volume":"11","author":"FT Fellendorf","year":"2022","unstructured":"Fellendorf FT, Manchia M, Squassina A et al (2022) Is poor lithium response in individuals with bipolar disorder associated with increased degradation of tryptophan along the kynurenine pathway? Results of an exploratory study. J Clin Med 11:2517. https:\/\/doi.org\/10.3390\/JCM11092517","journal-title":"J Clin Med"},{"key":"1519_CR66","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4137\/IJTR.S2318","volume":"2","author":"N Braidy","year":"2009","unstructured":"Braidy N, Grant R, Brew BJ et al (2009) Effects of kynurenine pathway metabolites on intracellular NAD synthesis and cell death in human primary astrocytes and neurons. Int J Tryptophan Res 2:61\u201369. https:\/\/doi.org\/10.4137\/IJTR.S2318","journal-title":"Int J Tryptophan Res"},{"key":"1519_CR67","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4137\/IJTR.S7052","volume":"4","author":"N Braidy","year":"2011","unstructured":"Braidy N, Guillemin GJ, Grant R (2011) Effects of kynurenine pathway inhibition on NAD metabolism and cell viability in human primary astrocytes and neurons. Int J Tryptophan Res 4:29\u201337. https:\/\/doi.org\/10.4137\/IJTR.S7052","journal-title":"Int J Tryptophan Res"},{"key":"1519_CR68","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/J.EURONEURO.2014.07.015","volume":"24","author":"E Plitman","year":"2014","unstructured":"Plitman E, Nakajima S, de la Fuente-Sandoval C et al (2014) Glutamate-mediated excitotoxicity in schizophrenia: a review. Eur Neuropsychopharmacol 24:1591\u20131605. https:\/\/doi.org\/10.1016\/J.EURONEURO.2014.07.015","journal-title":"Eur Neuropsychopharmacol"},{"key":"1519_CR69","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/J.JPSYCHIRES.2020.02.032","volume":"124","author":"P Shah","year":"2020","unstructured":"Shah P, Plitman E, Iwata Y et al (2020) Glutamatergic neurometabolites and cortical thickness in treatment-resistant schizophrenia: implications for glutamate-mediated excitotoxicity. J Psychiatr Res 124:151\u2013158. https:\/\/doi.org\/10.1016\/J.JPSYCHIRES.2020.02.032","journal-title":"J Psychiatr Res"},{"key":"1519_CR70","doi-asserted-by":"publisher","first-page":"e982","DOI":"10.1038\/TP.2016.238","volume":"6","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Catts VS, Sheedy D et al (2016) Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation. Transl Psychiatry 6:e982. https:\/\/doi.org\/10.1038\/TP.2016.238","journal-title":"Transl Psychiatry"},{"key":"1519_CR71","doi-asserted-by":"publisher","first-page":"146463","DOI":"10.1016\/J.BRAINRES.2019.146463","volume":"1724","author":"D Wu","year":"2019","unstructured":"Wu D, Lv P, Li F et al (2019) Association of peripheral cytokine levels with cerebral structural abnormalities in schizophrenia. Brain Res 1724:146463. https:\/\/doi.org\/10.1016\/J.BRAINRES.2019.146463","journal-title":"Brain Res"},{"key":"1519_CR72","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/J.0065-1591.2000.0AP25.X","volume":"401","author":"A Leung","year":"2000","unstructured":"Leung A, Chue P (2000) Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand Suppl 401:3\u201338. https:\/\/doi.org\/10.1111\/J.0065-1591.2000.0AP25.X","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"1519_CR73","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s12640-019-00112-z","volume":"37","author":"HK Al-Hakeim","year":"2020","unstructured":"Al-Hakeim HK, Almulla AF, Maes M (2020) The neuroimmune and neurotoxic fingerprint of major neurocognitive psychosis or deficit schizophrenia: a supervised machine learning study. Neurotox Res 37:753\u2013771. https:\/\/doi.org\/10.1007\/s12640-019-00112-z","journal-title":"Neurotox Res"},{"key":"1519_CR74","doi-asserted-by":"publisher","first-page":"747","DOI":"10.2174\/1568026620666200128143948","volume":"20","author":"HK Al-Hakeim","year":"2020","unstructured":"Al-Hakeim HK, Almulla AF, Al-Dujaili AH, Maes M (2020) Construction of a neuro-immune-cognitive pathway-phenotype underpinning the phenome of deficit schizophrenia. Curr Top Med Chem 20:747\u2013758. https:\/\/doi.org\/10.2174\/1568026620666200128143948","journal-title":"Curr Top Med Chem"},{"key":"1519_CR75","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1007\/s12035-021-02343-8","volume":"58","author":"M Maes","year":"2021","unstructured":"Maes M, Vojdani A, Sirivichayakul S et al (2021) Inflammatory and oxidative pathways are new drug targets in multiple episode schizophrenia and leaky gut, Klebsiella pneumoniae, and C1q immune complexes are additional drug targets in first episode schizophrenia. Mol Neurobiol 58:3319\u20133334. https:\/\/doi.org\/10.1007\/s12035-021-02343-8","journal-title":"Mol Neurobiol"},{"key":"1519_CR76","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/S11011-021-00685-9","volume":"36","author":"HK Al-Hakeim","year":"2021","unstructured":"Al-Hakeim HK, Mousa RF, Al-Dujaili AH, Maes M (2021) In schizophrenia, non-remitters and partial remitters to treatment with antipsychotics are qualitatively distinct classes with respect to neurocognitive deficits and neuro-immune biomarkers: results of soft independent modeling of class analogy. Metab Brain Dis 36:939\u2013955. https:\/\/doi.org\/10.1007\/S11011-021-00685-9","journal-title":"Metab Brain Dis"},{"key":"1519_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1092852921000419","volume":"12","author":"M Maes","year":"2021","unstructured":"Maes M, Kanchanatawan B (2021) In (deficit) schizophrenia, a general cognitive decline partly mediates the effects of neuro-immune and neuro-oxidative toxicity on the symptomatome and quality of life. CNS Spectr 12:1\u201310. https:\/\/doi.org\/10.1017\/S1092852921000419","journal-title":"CNS Spectr"},{"key":"1519_CR78","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/schbul\/sbaa157","volume":"47","author":"K Lim","year":"2021","unstructured":"Lim K, Smucny J, Barch DM et al (2021) Cognitive subtyping in schizophrenia: a latent profile analysis. Schizophr Bull 47:712\u2013721. https:\/\/doi.org\/10.1093\/schbul\/sbaa157","journal-title":"Schizophr Bull"},{"key":"1519_CR79","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/S00406-021-01237-Z","volume":"271","author":"HF North","year":"2021","unstructured":"North HF, Bruggemann J, Cropley V et al (2021) Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions. Eur Arch Psychiatry Clin Neurosci 271:595\u2013607. https:\/\/doi.org\/10.1007\/S00406-021-01237-Z","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1519_CR80","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4137\/IJTR.S40332","volume":"9","author":"J de Bie","year":"2016","unstructured":"de Bie J, Lim CK, Guillemin GJ (2016) Progesterone alters kynurenine pathway activation in IFN-\u03b3-activated macrophages\u2014relevance for neuroinflammatory diseases. Int J Tryptophan Res 9:89\u201393. https:\/\/doi.org\/10.4137\/IJTR.S40332","journal-title":"Int J Tryptophan Res"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-022-01519-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-022-01519-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-022-01519-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T05:07:20Z","timestamp":1692853640000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-022-01519-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,2]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["1519"],"URL":"https:\/\/doi.org\/10.1007\/s00406-022-01519-0","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,2]]},"assertion":[{"value":"13 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose. The authors have no conflict of interest to declare that are relevant to the content of this article. All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript. The authors have no financial or proprietary interests in any material discussed in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}